You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
NLRP12
NACHT, LRR and PYD domains-containing protein 12

Protein Summary
Description
May mediate activation of CASP1 via ASC and promote activation of NF-kappa-B via IKK. This gene encodes a member of the CATERPILLER family of cytoplasmic proteins. The encoded protein, which contains an N-terminal pyrin domain, a NACHT domain, a NACHT-associated domain, and a C-terminus leucine-rich repeat region, functions as an attenuating factor of inflammation by suppressing inflammatory responses in activated monocytes. Mutations in this gene cause familial cold autoinflammatory syndrome type 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000324134
  • ENSP00000319377
  • ENSG00000142405
  • ENST00000391773
  • ENSP00000375653
  • ENST00000391775
  • ENSP00000375655

Symbol
  • NALP12
  • PYPAF7
  • RNO
  • RNO
  • PAN6
  • RNO2
  • FCAS2
  • NALP12
  • PYPAF7
  • CLR19.3
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
biological process
0.99
molecular function
0.93
protein domain
0.85
tissue sample
0.67
transcription factor
0.57


Protein Classes
No PANTHER Classes or DTO Classes found
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 190.36   (req: < 5)
Gene RIFs: 42   (req: <= 3)
Antibodies: 301   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 190.36   (req: >= 5)
Gene RIFs: 42   (req: > 3)
Antibodies: 301   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 24
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0